EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H27N2O.Cl.H2O |
| Net Charge | 0 |
| Average Mass | 328.884 |
| Monoisotopic Mass | 328.19176 |
| SMILES | CCC[NH+]1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.O.[Cl-] |
| InChI | InChI=1S/C17H26N2O.ClH.H2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3;;/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20);1H;1H2/t15-;;/m0../s1 |
| InChIKey | VSHFRHVKMYGBJL-CKUXDGONSA-N |
| Roles Classification |
|---|
| Application: | local anaesthetic Any member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (S)-ropivacaine hydrochloride hydrate (CHEBI:34954) has part (S)-ropivacaine hydrochloride (anhydrous) (CHEBI:60803) |
| (S)-ropivacaine hydrochloride hydrate (CHEBI:34954) has role local anaesthetic (CHEBI:36333) |
| (S)-ropivacaine hydrochloride hydrate (CHEBI:34954) is a hydrate (CHEBI:35505) |
| IUPAC Names |
|---|
| (2S)-2-[(2,6-dimethylphenyl)carbamoyl]-1-propylpiperidinium chloride—water(1/1) |
| (2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride—water (1/1) |
| Synonyms | Source |
|---|---|
| ropivacaine hydrochloride | ChemIDplus |
| (S)-(−)-1-propylpiperidine-2-carboxylic acid (2,6-dimethylphenyl)amide hydrochloride monohydrate | ChemIDplus |
| (S)-(−)-1-propyl-2',6'-pipecoloxylidine hydrochloride monohydrate | ChemIDplus |
| (S)-ropivacaine hydrochloride monohydrate | ChEBI |
| L-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide hydrochloride monohydrate | ChEBI |
| L-ropivacaine hydrochloride monohydrate | ChEBI |
| Brand Name | Source |
|---|---|
| Naropin | DrugBank |
| Manual Xrefs | Databases |
|---|---|
| D04048 | KEGG DRUG |
| DB00296 | DrugBank |
| WO2009044404 | Patent |
| Registry Numbers | Sources |
|---|---|
| Reaxys:5421768 | Reaxys |
| CAS:132112-35-7 | KEGG DRUG |
| CAS:132112-35-7 | ChemIDplus |
| Citations |
|---|